Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Comparison of the transcriptional network between acinar and ductal cells in pancreatic cancer.
EF 2022-23
Résumé
Although pancreatic cancer diagnoses are low compared to other cancers, in 2022, pancreatic cancer ranked the 3rd highest leading cause of cancer-related death in Canada. The most common type of pancreatic neoplasm is pancreatic ductal adenocarcinoma (PDAC), accounting for over 90% of the cases with an average 5-year survival rate of under 10%. The main difficulties in treating PDAC are a lack of symptoms until metastasis, limited early detection methods, and resistance to therapies. The presence of many non-targetable mutations in PDAC results in the use of non-specific methods of chemotherapy that are relatively ineffective. Thus, current research is on identifying markers that can help diagnose patients with PDAC.
The pancreas contains exocrine glands, composed of two epithelial cell types, acinar and ductal. These two cells work together to release enzymes into the duodenum. Mutations that arise in these cells lead to PDAC of two transcriptional subtypes, classical and basal. Using genetically engineered mouse models (GEMM) developed in the Kopp lab, I can specifically induce acinar or ductal cells to form PDAC. The GEMMs can be used to examine different transcriptional networks between acinar- and ductal-cell derived PDAC. I hypothesize that differences in acinar and ductal cell gene expression lead to the generation of PDAC subtypes. I will use RNA-seq and ATAC-seq to identify open chromatin associated with regulatory regions and the potential transcription factors associated with the differences in gene expression. The results of my research could help discriminate whether different cellular origins are associated with known or novel PDAC subtypes.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486613
Name
Chu Ken H
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Comparison of the transcriptional network between acinar and ductal cells in pancreatic cancer.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Clinical Datasets; Cancer Genomics; Cancer Subtype; Cell Lineage; Cell Of Origin; Mouse Model; Pancreatic Ductal Adenocarcinoma (Pdac); Pdac Cell Lines; Transcription Factors; Tumor Microenvironment
Abstract
Although pancreatic cancer diagnoses are low compared to other cancers, in 2022, pancreatic cancer ranked the 3rd highest leading cause of cancer-related death in Canada. The most common type of pancreatic neoplasm is pancreatic ductal adenocarcinoma (PDAC), accounting for over 90% of the cases with an average 5-year survival rate of under 10%. The main difficulties in treating PDAC are a lack of symptoms until metastasis, limited early detection methods, and resistance to therapies. The presence of many non-targetable mutations in PDAC results in the use of non-specific methods of chemotherapy that are relatively ineffective. Thus, current research is on identifying markers that can help diagnose patients with PDAC.
The pancreas contains exocrine glands, composed of two epithelial cell types, acinar and ductal. These two cells work together to release enzymes into the duodenum. Mutations that arise in these cells lead to PDAC of two transcriptional subtypes, classical and basal. Using genetically engineered mouse models (GEMM) developed in the Kopp lab, I can specifically induce acinar or ductal cells to form PDAC. The GEMMs can be used to examine different transcriptional networks between acinar- and ductal-cell derived PDAC. I hypothesize that differences in acinar and ductal cell gene expression lead to the generation of PDAC subtypes. I will use RNA-seq and ATAC-seq to identify open chromatin associated with regulatory regions and the potential transcription factors associated with the differences in gene expression. The results of my research could help discriminate whether different cellular origins are associated with known or novel PDAC subtypes.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chu, Ken H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~